| Product Name | MF | CAS | Details |
|---|
| 1-Palmitoyl-sn-glycerol 3-phosphate | C19H38NaO7P | 7220-34-0 | Details |
| 4-Hydroperoxyifosfamide | C7H15Cl2N2O4P | 39800-28-7 | Details |
| 6-Azauridine triphosphate | C8H14N3O15P3 | 6198-30-7 | Details |
| 6-Methoxypurine arabinoside | C11H14N4O5 | 91969-06-1 | Details |
| AC-099 | C9H8ClF3N4 | 849459-88-7 | Details |
| Activated A Subunit | C38H37ClN7O4P | 1155373-30-0 | Details |
| Activated C Subunit | C37H37ClN5O5P | 1155373-31-1 | Details |
| Activated T Subunit | C31H34ClN4O5P | 1155373-34-4 | Details |
| And1-IN-1 | C15H11BCl2O2 | 2451028-69-4 | Details |
| Angiogenesis inhibitor 4 | C27H30ClN5O5 | 417719-77-8 | Details |
| Anticancer agent 103 | 2914922-78-2 | Details |
| Anti-inflammatory agent 43 | C34H42O22 | 2364631-99-0 | Details |
| Antiproliferative agent-33 | 477542-73-7 | Details |
| Antiproliferative agent-41 | C20H20O4 | 225652-93-7 | Details |
| BMS-332 | C29H27F2N5O | 2407892-15-1 | Details |
| BMS-496 | C26H22BrF2N5O3 | 2407854-31-1 | Details |
| CIDD-0149897 | C15H10FNO3 | 2862784-20-9 | Details |
| Cisd2 agonist 2 | C14H14N2O4S | 2916371-59-8 | Details |
| CMPD167 | C35H47FN4O2 | 313994-79-5 | Details |
| Deoxyharringtonine | C28H37NO8 | 36804-95-2 | Details |
| DGKζ-IN-3 | C20H16ClF3N4O3S | 2732901-70-9 | Details |
| DHX9-IN-1 | C21H21F2N5O3S | 2973747-89-4 | Details |
| Fenquinotrione | C22 H17 Cl N2 O5 | 1342891-70-6 | Details |
| Glycine, N-[(1,1-dimethylethoxy)carbonyl]thio-L-phenylalanyl-, methyl ester | C17H24N2O5S | 128421-85-2 | Details |
| Glycolate oxidase-IN-1 | C12H8O5 | 330977-65-6 | Details |
| GPAT-IN-1 | C21H26ClNO4S | 1204347-51-2 | Details |
| HAPSBC | C15H15N3S2 | 1376545-81-1 | Details |
| HD-2a | C18H18O6 | 606148-05-4 | Details |
| HSP70/SIRT2-IN-2 | C17H13N3S3 | 1796557-72-6 | Details |
| Immune cell migration-IN-2 | C26H22Cl2NO7PS | 2260679-24-9 | Details |
| Keap1-Nrf2-IN-10 | C25H22I2N4O7S2 | 2445349-54-0 | Details |
| LFS-1107 | C12H11N5OS2 | 1799330-91-8 | Details |
| MAO-B-IN-27 | C16H16F3NO.ClH | 788824-83-9 | Details |
| Metabutoxycaine | C17H28N2O3 | 3624-87-1 | Details |
| Murabutide | C23H40N4O11 | 74817-61-1 | Details |
| NCP2 Anchor | C38H36N4O8 | 1380600-13-4 | Details |
| NLRP3 agonist 1 | C15H16N6 | 2454019-69-1 | Details |
| NOX2-IN-1 | C22H22N4O3 | 2648709-25-3 | Details |
| NSC309401 dihydrochloride | C17H17ClN6 | 77681-42-6 | Details |
| Dobutamine tartrate | C22H29NO9 | 101626-66-8 | Details |
| PIM-IN-2 | C19H22N4O2 | 1006699-45-1 | Details |
| Piperidione | C9H15NO2 | 77-03-2 | Details |
| PLK1/p38γ-IN-1 | C21H26ClN3O2 | 2418614-81-8 | Details |
| PTC258 | C16H18ClN3S2 | 2476724-74-8 | Details |
| Pterostilbene-isothiocyanate | C18H19N3O3S | 1616974-29-8 | Details |
| RCB16007 | 2952530-26-4 | Details |
| Remternetug | 2571940-41-3 | Details |
| Riboxin | C10H14N4O11P2 | 86-04-4 | Details |
| Rocbrutinib | C42H51N9O5 | 2485861-07-0 | Details |
| SORT-PGRN interaction inhibitor 2 | C19H31NO | 1008233-79-1 | Details |
| S-Pantoprazole sodium trihydrate | C16H15F2N3O4S.3H2O.Na | 1416988-58-3 | Details |
| TMDJ-035 | C16H12F3N5O | 2681302-83-8 | Details |
| Trabikibart | 2643974-98-3 | Details |
| Tubulin polymerization-IN-56 | C22H21N3O3.ClH | 2966790-98-5 | Details |
| VRT-534 | C25H24ClN3O4S | 926664-32-6 | Details |
| WRN inhibitor 3 | C20H20N2O5S | 2923009-48-5 | Details |
| WRN inhibitor 4 | C16H14N2O5S | 2923009-45-2 | Details |
| WRN inhibitor 5 | C23H20N2O6S | 2923009-95-2 | Details |
| ZH8667 | C14H14FN | 910387-04-1 | Details |
| α-Pyridoin | C12H12N2O2 | 1141-05-5 | Details |
| 2-PCCA hydrochloride | C30H38ClN3O | 1609563-70-3 | Details |
| BEBT-109 | C27H32N8O3 | 2050906-40-4 | Details |
| Duvakitug | 2750005-84-4 | Details |
| Tripeptide-32 | C12H22N4O5 | 1185583-20-3 | Details |
| NSC309401 | C17H16N6 | 750522-61-3 | Details |
| GPR88-IN-1 | C25H28N4O2 | 714265-50-6 | Details |
| 3β-Hydroxy-lup-20(29)-en-16-one | C30H48O2 | 65043-60-9 | Details |
| Hydroxy-PP-Me | C16 H18 N4 O | 833481-77-9 | Details |
| Tirfipiravir | C14H17N3O8 | 2759996-93-3 | Details |
| Ibuzatrelvir | C21H30F3N5O5 | 2755812-39-4 | Details |
| Usnoflast | C21H29N3O3S | 2455519-86-3 | Details |
| TIE-2/VEGFR-2 kinase-IN-4 | C26H17F4N5O4 | 433224-29-4 | Details |
| TIE-2/VEGFR-2 kinase-IN-3 | C23H17F4N5O3S | 433224-09-0 | Details |
| ASN90 | C17H21N5O3S | 1884154-02-2 | Details |
| DGKα-IN-8 | C23H19ClF3N5O | 2886717-70-8 | Details |
| DGKζ-IN-4 | C23H25ClF3N3O6 | 2778366-77-9 | Details |
| DGKα-IN-4 | C30H29N5O4 | 2648723-43-5 | Details |
| DGKα-IN-3 | C26H27F3N4O3 | 2648418-86-2 | Details |
| DGKα-IN-2 | C23H22F3N3O4 | 2648556-92-5 | Details |
| Raf inhibitor 3 | C18H19FN8O2S | 1662682-11-2 | Details |
| DDR1/2 inhibitor-2 | C25H19F3N6O2 | 2908756-11-4 | Details |
| ALPK1-IN-3 | C20H16F2N4OS | 2765633-73-4 | Details |
| H4R antagonist 2 | C13H17N5O | 1148115-99-4 | Details |
| NSC 48160 | C18 H29 N O | 6640-90-0 | Details |
| Anti-MRSA agent 8 | C20H30O5 | 3118-36-3 | Details |
| Antiviral agent 35 | 2760972-52-7 | Details |
| Sirt1/2-IN-3 | C17H14ClNO4S | 301313-42-8 | Details |
| Antileishmanial agent-23 | C20H17N3O4S2 | 745033-86-7 | Details |
| PD-L1-IN-3 | C19H15FN2OS.Cl | 2953044-29-4 | Details |
| SARS-CoV-2-IN-44 | C18H16O5 | 1311271-71-2 | Details |
| RSV L-protein-IN-4 | C32H35N5O6 | 851657-60-8 | Details |
| MC-EVCit-PAB-MMAE | C73H112N12O18 | 2873452-49-2 | Details |
| 4-Thiouridine 5′-triphosphate tetralithium | C9H15N2O14P3S.4Li | 20188-72-1 | Details |
| Cav 3.2 inhibitor 4 | C21H32Cl2N4O3 | 1416984-93-4 | Details |
| STAT6-IN-2 | C28H31N5O2 | 1355594-85-2 | Details |
| WRN inhibitor 2 | C15H11F3N2O5S2 | 2923009-56-5 | Details |
| URAT1 inhibitor 6 | C9H8BrN3O2S2.Na | 2244807-49-4 | Details |
| CBP-IN-1 | C27H33F2N7O | 1936431-44-5 | Details |
| h15-LOX-2 inhibitor 1 | C17H13F3N2S | 478040-08-3 | Details |
| KRAS G12C inhibitor 59 | 2914919-88-1 | Details |
| Product Total： Product Page： | ||||
| 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 | ||||